Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
British American Tobacco ( (GB:BATS) ) has issued an announcement.
British American Tobacco p.l.c. announced the repurchase of 141,817 of its ordinary shares as part of its ongoing buyback program. The shares were acquired at prices ranging from 3,546.00p to 3,573.00p and will be canceled, reducing the total number of shares in issue. This move is part of the company’s strategy to manage its capital structure and return value to shareholders, potentially impacting its share price and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
Spark’s Take on GB:BATS Stock
According to Spark, TipRanks’ AI Analyst, GB:BATS is a Neutral.
British American Tobacco’s strong financial performance and cash flow generation are significant positives. Technical indicators suggest moderate bullish momentum, while valuation is attractive due to a high dividend yield despite a high P/E ratio. Earnings call guidance indicates cautious optimism amid market challenges. Corporate events, including share buybacks, further enhance shareholder confidence and value.
To see Spark’s full report on GB:BATS stock, click here.
More about British American Tobacco
British American Tobacco p.l.c. is a leading company in the tobacco industry, primarily engaged in the production and sale of cigarettes and other nicotine products. The company operates globally, focusing on delivering high-quality tobacco products to a wide range of markets.
Average Trading Volume: 6,032,603
Technical Sentiment Signal: Buy
Current Market Cap: £77.52B
See more insights into BATS stock on TipRanks’ Stock Analysis page.